OTCMKTS:SHTDY Sinopharm Group (SHTDY) Stock Price, News & Analysis $12.59 +0.05 (+0.36%) As of 03:57 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartDividendFinancialsHeadlinesShort Interest About Sinopharm Group Stock (OTCMKTS:SHTDY) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Sinopharm Group alerts:Sign Up Key Stats Today's Range$12.26▼$12.6450-Day Range$12.21▼$13.4952-Week Range$10.13▼$16.31Volume6,727 shsAverage Volume14,214 shsMarket CapitalizationN/AP/E Ratio2.52Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewSinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology, investment, goods and technology import and export, business consulting, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.Read More… Remove Ads Receive SHTDY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sinopharm Group and its competitors with MarketBeat's FREE daily newsletter. Email Address SHTDY Stock News Headlines3 Compelling Dividend Stocks Offering Yields Up To 5.1%January 28, 2025 | finance.yahoo.comSinopharm Group Schedules EGM for Board Director AppointmentsJanuary 19, 2025 | tipranks.com🚨This Week: The Political Fallout from Nvidia’s AI ConferenceSomething big is happening TWO days from now on March 20th — and the political world isn’t ready for it. Nvidia is poised to unveil a groundbreaking AI breakthrough, and the implications could shake Washington, Wall Street, and Main Street alike. While the media focuses on tariff chaos and global conflicts, no one is paying attention to the AI revolution that could shift economic power overnight THIS THURSDAY.March 14, 2025 | InvestorPlace (Ad)Sinopharm Accord Projects Notable Profit Decline for 2024January 19, 2025 | tipranks.comSinopharm Group Proposes New Director AppointmentsJanuary 8, 2025 | tipranks.comAnalysts Offer Insights on Healthcare Companies: BioLife Solutions (BLFS) and Sinopharm Group Co (OtherSHTDF)December 12, 2024 | markets.businessinsider.com3 Dividend Stocks Yielding Up To 4.5%November 8, 2024 | finance.yahoo.comFDA Approves New Schizophrenia Drug in 70-Year FirstSeptember 28, 2024 | msn.comSee More Headlines SHTDY Stock Analysis - Frequently Asked Questions How have SHTDY shares performed this year? Sinopharm Group's stock was trading at $13.57 at the beginning of the year. Since then, SHTDY shares have decreased by 7.3% and is now trading at $12.5850. View the best growth stocks for 2025 here. How do I buy shares of Sinopharm Group? Shares of SHTDY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today3/14/2025Next Earnings (Estimated)3/21/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Distribution Sub-IndustryPersonal Services Current SymbolOTCMKTS:SHTDY CIK1556605 Webwww.sinopharmgroup.com.cn Phone86-21-2305-2666FaxN/AEmployees115,959Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio2.52 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report This page (OTCMKTS:SHTDY) was last updated on 3/14/2025 by MarketBeat.com Staff From Our PartnersTrump’s new tariffs could break China’s grip on manufacturingLooming trade wars have China scrambling… Over 90% of global corporate executives said they are shutting do...Weiss Ratings | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredElon’s desperate gambleWarning: "DOGE Collapse" Imminent After months of cost-cutting, controversy, and media buzz, DOGE is on the...Altimetry | SponsoredIs 2025 really the best time to get rich in American history?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredMore important than tariffs for your stocksMost people are obsessed with Trump's on-again, off-again tariffs. Yes, the economic uncertainly is playin...Chaikin Analytics | SponsoredMarch 18th: Gold SHOCK?Starting March 18th, a major shift could send gold soaring — or crashing. Either way this shift goes... ...InvestorPlace | SponsoredSomething strange is happening in Virginia…In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sinopharm Group Co. Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sinopharm Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.